Tricyclic anilide spirohydantoin CGRP receptor antagonists

Details for Australian Patent Application No. 2005285083 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Theberge, Cory R.; Bell, Ian M.; Zartman, C. Blair; Zhang, Xufang; Gallicchio, Steven N.

Agent Spruson & Ferguson

Pub. Number AU-B-2005285083

PCT Pub. Number WO2006/031676

Priority 60/609,294 13.09.04 US

Filing date 9 September 2005

Wipo publication date 23 March 2006

Acceptance publication date 10 March 2011

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4166 (2006.01)

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

15 March 2007 PCT application entered the National Phase

  PCT publication WO2006/031676 Priority application(s): WO2006/031676

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

10 March 2011 Application Accepted

  Published as AU-B-2005285083

7 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005285090-Compositions containing uridine, and methods utilizing same

2005285078-Wireless communication methods and components for facilitating multiple network type compatibility